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Type 1 diabetes patients are provided guidance and structured education on adjusting their 
meal time bolus-insulin dose based on meal carbohydrate content. However, recent research 
in patients using continuous subcutaneous insulin infusion (CSII) has highlighted the role of 
dietary fat in increasing prandial insulin requirements, particularly late into the postprandial 
period (1, 2). 
 
Many patients are treated with basal-bolus insulin injections, which is a less flexible method 
of insulin therapy than CSII; for example, patients are unable to dual wave/extended bolus at 
meal time. It is important to consider that patients are encouraged to carbohydrate count and 
administer rapid-acting insulin units at meal-time, and that the time-action profiles of 
lispro/aspart vary in a dose dependent manner; while the peak insulin concentration after a 
pre-meal bolus usually occurs within the first 60 minutes (3), the peak action is usually 
observed between 90-120 minutes, and this duration can vary between 4-6 hours. However, 
peak postprandial lipemia occurs after 3-4 hours (4), which can promote acute peripheral 
insulin resistance and increase hepatic glucose output (5), and thus, hyperglycemia. 
 
We investigated the influence of rapid-acting insulin dose and timing after high-carbohydrate 
high-fat meals in type 1 diabetes patients using insulin analogue injections.  
 
10 male patients (mean±SD; age 264 years, BMI 25.41.6, diabetes duration 175 years, 
age at diagnosis 94 years; HbA1c 52.55.9 mmol/mol[7.00.5%]) using insulin aspart, and 
either basal insulin glargine (n=8) or detemir (n=2) attended the Newcastle NIHR Clinical 
Research Facility at 07:30h on four occasions.  
 Experimental trials were randomized and involved consuming either a 1) low-fat meal with 
bolus insulin dictated by carbohydrate counting (Low-Fat100%), 2) high-fat meal with bolus 
insulin dictated by carbohydrate counting (High-Fat100%), 3) high-fat meal with a bolus 
insulin dose increased by 30% (High-Fat130%), or 4) high-fat meal with bolus insulin 
dictated by carbohydrate counting, with an additional 30% administered at 3-h post-meal 
(High-FatSplit). Meals were matched for carbohydrate and protein content, but differed in 
fat (low fat: 68 g carbohydrate, 26 g protein, 5 g fat; High-fat: 68 g carbohydrate, 26 g 
protein, 55 g fat). Interval blood samples were collected over a 6 hour post-prandial period 
and were processed for glucose (Biosen C-Line, EKF-Diagnostic GmbH, London) and 
exogenous insulin (Invitron Insulin-Assay, Invitron, Monmouth, UK). 
 
Glucose and insulin are presented in Figure 1-A and B, respectively. High-Fat100% was 
associated with late-hyperglycemia, while during High-Fat130%, 60% of patients 
experienced hypoglycemia (glucose<3.9 mmol/L), with no incidences under the other 
conditions. Post-prandial glycemic excursions (time-course changes and area under the 
curve) were similar between Low-Fat100% and High-FatSplit, despite the additional 50 g 
of fat consumed in the latter trial.  
 
When a meal has a high-carbohydrate and high-fat content, using the carbohydrate counting 
method for insulin dose adjustments at meal time, and administering additional bolus-insulin 
units 3 hours later, provides similar postprandial glucose control to a meal containing 
negligible fat, without causing hypoglycemia. Patients should be advised that increasing 
meal-time insulin dose alone is not an effective strategy, and is an approach that may increase 
the risk of early post-prandial hypoglycemia.  
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 Figure Legends 
Figure 1 A-B. A Time course changes in blood glucose; B in Serum Insulin. Blue trace = 
Low-Fat100%; Black trace = High-Fat100%; Red trace = High-FatSplit; Green trace = 
High-Fat130%. Data presented as mean±SD (n=10). * indicates that all conditions are 
significantly different from High-Fat130%, ** indicates that all conditions are significantly 
different from High-Fat100% and High-Fat130%. 
 
 
